Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)

NCT00887263 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Chronic Graft vs Host Disease

Interventions

DRUG: Budesonide
DRUG: Placebo

Sponsor

Dr. Falk Pharma GmbH